Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis

被引:27
作者
Berends, Maartje A. M. [1 ]
van Oijen, Martijn G. H. [2 ]
Snoek, Josje [2 ]
de Kerkhof, Peter C. M. van
Drenth, Joost P. H. [2 ]
van Krieken, J. Han [3 ]
de Jong, Elke M. G. J. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, NL-6525 GL Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 GL Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 GL Nijmegen, Netherlands
关键词
D O I
10.1001/archderm.143.12.1515
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: To determine the interobserver reliability of the Roenigk score as a classification system of liver damage and its possible consequences for clinical practice. Design: Retrospective study. Setting: Academic research. Patients: One hundred sixty liver biopsy specimens from patients with psoriasis receiving methotrexate treatment were rereviewed and analyzed blindly by an experienced pathologist with an interest in liver pathologic conditions. Main Outcome Measure: Interobserver variation was evaluated using K statistics. Results: A high concordance was present in the evaluation of the Roenigk grade of fibrosis (weighted kappa=0.73; 95% confidence interval, 0.63-0.83). Agreement was good regarding the number of biopsy specimens for patients whose clinical management should be changed (kappa=0.71; 95% confidence interval, 0.56-0.87). Conclusion: The Roenigk classification in the assessment of liver fibrosis is a reliable scoring system.
引用
收藏
页码:1515 / 1519
页数:5
相关论文
共 25 条
[1]   Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified? [J].
Aithal, GP ;
Haugk, B ;
Das, S ;
Card, T ;
Burt, AD ;
Record, CO .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (04) :391-399
[2]  
BEDOSSA P, 1994, HEPATOLOGY, V20, P15
[3]   Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients:: Fibrotest predicts the presence and Fibroscan® predicts the absence of significant liver fibrosis [J].
Berends, Maartje A. M. ;
Snoek, Josje ;
de Jong, Elke M. G. J. ;
Van Krieken, J. Han ;
de Knegt, Robert J. ;
van Oijen, Martijn G. H. ;
van de Kerkhof, Peter C. M. ;
Drenth, Joost. P. H. .
LIVER INTERNATIONAL, 2007, 27 (05) :639-645
[4]  
BOFFA MJ, 1995, BRIT J DERMATOL, V133, P774
[5]   Current concepts: Liver biopsy. [J].
Bravo, AA ;
Sheth, SG ;
Chopra, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) :495-500
[6]   Grading and staging the histopathological lesions of chronic hepatitis. The Knodell histology activity index and beyond [J].
Brunt, EM .
HEPATOLOGY, 2000, 31 (01) :241-246
[7]   The evolving role of liver biopsy [J].
Campbell, MS ;
Reddy, KR .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (03) :249-259
[8]   Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis [J].
Chalmers, RJG ;
Kirby, B ;
Smith, A ;
Burrows, P ;
Little, R ;
Horan, M ;
Hextall, JM ;
Smith, CH ;
Klaber, M ;
Rogers, S .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (03) :444-450
[9]   HIGH AGREEMENT BUT LOW KAPPA .2. RESOLVING THE PARADOXES [J].
CICCHETTI, DV ;
FEINSTEIN, AR .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1990, 43 (06) :551-558
[10]   Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis [J].
Goldin, RD ;
Goldin, JG ;
Burt, AD ;
Dhillon, PA ;
Hubscher, S ;
Wyatt, J ;
Patel, N .
JOURNAL OF HEPATOLOGY, 1996, 25 (05) :649-654